BioCentury
ARTICLE | Clinical News

Tuberculosis: Preliminary Phase I data

March 19, 2007 7:00 AM UTC

Preliminary data from an open-label, Dutch Phase I trial in 36 healthy volunteers showed that ICLL's TB vaccine was safe and stimulated a strong immunogenic T cell response. ...